CLEARWATER, Fla., April 24, 2012 /PRNewswire/ -- Golden Valley
Development, Inc. (OTC: GVDI) (www.goldenvalleydev.com) is pleased
to announce the appointment of Milton Marshall PhD to its advisory board. Dr
Marshall will oversee the FDA regulatory handling for
Percuguard™ anti needle stick device, quality
control and the near-term introduction into broad dental and
medical markets, which potentially exceed one billion applications
annually.
Dr. Marshall holds a Ph.D. (biochemistry and virology) from the
University of Texas Health Science Center at
Houston Graduate School of Biomedical Sciences, followed by
a postdoctoral fellowship at the University of
Texas M.D. Anderson Cancer Center in Houston. Adjunct
academic appointments are currently held at a dental school and a
medical school. Professional certifications include
toxicology (American Board of Toxicology), Registered Quality
Assurance Professional - GLP (Society of Quality Assurance), and
Certified Clinical Research Professional (Society of Clinical
Research Associates). Career accomplishments include
experience as a principal investigator, study director, laboratory
director, and consultant in toxicology and regulatory compliance in
new product development. Specific areas of research and
development include preclinical and clinical drug, biologic,
medical device, and OTC product development.
Additional information about Dr. Marshall is available at
www.goldenvalleydev.com/management.
Kevin Sorrels, D.D.S., CEO of
GVDI, stated, "We are excited to bring Milton onto our Board of Advisors. The design
specifications require rigid quality assurance that will provide
the healthcare worker with needle stick protection and yet allow
for manual dexterity and tactile sensitivity. Milton brings the knowledge and experience
necessary to ensure that such exacting specifications are met."
Commented Dr. Marshall in accepting the position with GVDI,
"This product provides a solution for accidental needle sticks in
medical and dental procedures where other applications have been
remiss. I look forward to joining the production team and making
sure that the many qualities necessary for this product to be
successful are achieved."
About Golden Valley Development, Inc.
Golden Valley Development, Inc. is a publicly-traded product
development and technology licensing company based in Clearwater, FL. Through two of its
wholly-owned subsidiaries, its business plan is to manufacture and
market patented products in the health care and home consumer
markets, beginning with its first two products, "Cut
Stop™" and "PercuGuard.™"
For more information, please contact the company:
Golden Valley Development, Inc.
611 S. Fort Harrison Ave. # 380
Clearwater, FL 33756
Investor Hotline: 850-270-8650
Email: info@goldenvalleydev.com
Forward-Looking Statements
Portions of this press release contain forward-looking
statements and involve risks and uncertainties that could
materially affect expected results of operations, liquidity, cash
flows and business prospects.
SOURCE Golden Valley Development, Inc.